Will Supplement the Company's Growing Direct to Patient Clinical Trial Services
RESEARCH TRIANGLE PARK, N.C.,April 17, 2018/PRNewswire/ — Marken announced today their plans to develop a global home-based nursing network to supplement Marken's existing Direct to/from Patient (DTP/DFP) services. This new service will allow Marken to streamline the compliant delivery of clinical trial materials to patients homes and collect biologic samples in accordance with client's clinical protocols.
Marken plans to offer its clients new services which could include: intravenous infusion, blood draws including safety lab samples, biologic sampling such as pharyngeal and oral mucosal swabs as well as the clinical assessment of vital signs and other mobile based electronic data collection.
The new services will integrate with Marken's proprietary Maestro™ operating system for comprehensive shipment tracking from booking through delivery. Its existing 24/7 Patient Communications Center (PCC) and its Marken Viseo™ smartphone application will also be offered to enhance its DTP services. The Viseo online interface allows patients and nurses to track their home deliveries of clinical trial materials and the pickup of their biological specimens via their mobile device or personal computer. Nurses will also be able to drop bio sample boxes at local The UPS Stores®for direct shipment to the central laboratory, as previously announced.
Wes Wheeler, Marken's CEO, stated "the decision to develop our own nursing network was based on the strong growth we have seen in our Direct to Patient services which we currently offer in 51 countries. We note that 24% of pharmaceutical companies are moving to virtual or partially virtual trials and another 33% are expected to start 'siteless' trials in the near future. We expect this trend will continue to place a heavy demand for our services."
Kimberly Finn, who joined Marken as Vice President, Global Home Care and Direct to Patient Services, commented on the new service, "With integrated home care, Marken will be able to provide true patient-centricity throughout the clinical trial, withonecontact for the patient,onepoint of contact for the investigator site, andonepoint of contact for our clients."
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.